Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453882 · ClinicalTrials.gov registry record · NA
Uretal Flow Assessment During Gynecological Procedures
A NA study, sponsored by Ethicon.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00453882: Completed NA study, sponsored by Ethicon.
NCT00453882 is a NA study that has completed, run by Ethicon. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453882, a NA study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective is to evaluate the feasibility of using color Doppler ultrasound in ureteral flow assessment after uterine artery occlusion during a conservative gynecological procedure.
Interventions
- DEVICE flostat (TM) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-04 |
| Phase | NA |
What the finished NCT00453882 record still lists
NCT00453882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which flostat (TM) System is the first listed.
NCT00453882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00453882 about?
NCT00453882 is a clinical study titled "Uretal Flow Assessment During Gynecological Procedures". The objective is to evaluate the feasibility of using color Doppler ultrasound in ureteral flow assessment after uterine artery occlusion during a conservative gynecological procedure.
What is the current status of trial NCT00453882?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2006-11. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00453882?
The interventions under investigation include: flostat (TM) System (DEVICE).
Who is sponsoring clinical trial NCT00453882?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00453882's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia